While PSMA-RLT was generally well tolerated in this subpopulation, pathologically lowered HP, corresponding to CTCAE grade one and two, in anaemia especially, were very common among all patients even prior to first application of PSMA-RLT. This evidence concerns the gene FOLH1 and anemia (phenotype).